GFN News

A powerful closing address from David Sweanor, a pioneering public health lawyer, delivered at the 12th Global Forum on Nicotine (GFN). In this concluding keynote, he reflects on the diverse perspectives within the tobacco harm reduction community, the challenges posed by opposition to new technologies, and the global momentum toward reduced-risk nicotine products. David highlights historical patt...

Global Forum on Nicotine 2025 Closing remarks by David Sweanor by GFN.TV

As policymakers look ahead to 2026, experts from Ireland and the United States share one clear hope for tobacco harm reduction: protect vape flavors. In this discussion, Dr. Garrett McGovern and AG Tom Miller explains why flavors are critical to keeping adults away from smoking - and why banning them could backfire, leading to higher cigarette use, including among youth. He argues that enforcing a...

As 2026 approaches, policymakers face a critical choice: continue repeating failed tobacco strategies or finally listen to science, consumers, and real-world evidence. In this discussion, Fiona Patten and Fernando Bueno examine why Australia’s tobacco tax revenue has collapsed, how harm reduction products like vaping are being wrongly regulated, and what countries like Sweden and New Zealand have...

Discover how oral nicotine pouches could represent the next frontier in tobacco harm reduction, with a deep dive into their chemistry, toxicology, and real-world use data compared with cigarettes and traditional snus. In this Science Lab session, Chris presents new evidence on toxicant reduction, biomarkers of exposure and potential harm, pharmacokinetics, and user behavior across different market...

Join us for a fast-moving roundup of the most significant tobacco harm reduction developments of 2025. From FCTC COP11 controversies and global bans to new scientific insights, advocacy efforts, and major policy shifts, Will Godfrey breaks down the year’s biggest stories. Discover where progress is being made, where setbacks continue, and how real-world consumers are shaping the future of safer ni...

Join GFN.TV and Michael Landl from the World Vapors Alliance as they break down COP11’s impact on tobacco harm reduction. Discover how countries challenged WHO recommendations, delayed restrictive measures, and pushed for evidence-based policies. Learn what this means for EU regulations, harm reduction strategies, and the global fight for safer nicotine alternatives.

Join Joanna Junak on GFN News as she speaks with Kurt Yeo, co-founder of Vaping Saved My Life, about the key moments and conversations surrounding COP11. Kurt shares his impressions from the unofficial Good COP 2.0 meeting in Geneva and offers insights into the broader discussions on harm reduction and tobacco policy.

YouTube’s new AI enforcement wave looks less like a policy update and more like the World Health Organization’s crusade against nicotine. In this worrying GFN Interview, GrimmGreen shows how safer-nicotine content is now being flagged as “medical misinformation” under rules that echo the WHO’s narrative: nicotine equals harm—no nuance allowed. After sixteen years as one of the most trusted voices...

Next in our Science Lab sessions, Chloe Rose PhD presents on the importance of properly designed studies and trials to determine the safety and relative risk of nicotine products.

In this exclusive GFN News interview, Joanna Junak speaks with Nancy Loucas, CAPHRA Executive Coordinator, about the fallout from COP11 in Geneva and the controversial Dirty Ashtray Award given to New Zealand. Despite achieving significant reductions in smoking through regulated vaping and progressive harm reduction policies, New Zealand was criticized by the WHO FCTC Secretariat and its supportin...

Misunderstanding nicotine delivery: a discussion on nicotine pouches. PMI's Carrie Wade and Gizelle Baker discuss the problems with comparing nicotine content of pouches with combustible tobacco. #GFN25 Science Lab discussions

This GFN Voices 2025 episode brings together advocates, scientists and campaigners from around the world to share why the Global Forum on Nicotine matters, how tobacco harm reduction is being misunderstood, and why honest communication, access to safer products and open debate are essential for helping people move away from smoking.

In this episode of Science Lab, we break down the latest research comparing traditional cigarette smoking with heated tobacco products (HTPs). Using evidence from multiple clinical studies, she explains how switching completely from smoking to HTPs affects biomarkers of exposure, biomarkers of potential harm, reported symptoms, and overall risk profiles.

Former Iowa Attorney General Tom Miller—America’s longest-serving AG and a principal architect of the Master Settlement Agreement—joins GFN.TV with a clear warning: the U.S. is making extraordinary progress against combustible tobacco, yet the public isn’t hearing about it. Smoking has collapsed to historic lows, youth vaping has fallen 70% since 2019, and millions of adults have shifted to far sa...

Nigeria is experiencing increasing health impacts from smoking, and experts argue that harm reduction—not prohibition—is key to saving lives. In this GFN News episode, Joanna Junak interviews Uche Olatunji and Yusuf Adebisi on the major barriers to tobacco harm reduction in Nigeria, including widespread misinformation about nicotine and a lack of educational resources. They discuss community outre...

The media play a key role in shaping debates around THR. It is essential that information they communicate is accurate and reflects science and evidence. Misinformation and the impact it can have on consumers, and public health generally, is something we should avoid. A lack of knowledge, expertise and time to verify information provided – often by NGOs that allege to be working on behalf of publi...

Ireland has introduced the highest vape tax in the European Union — but experts warn it could backfire. In this episode of GFN News, Joanna Junak speaks with Will Godfrey of Filter about how the new €0.50/ml levy may reduce switching, misinform the public, and even risk increasing smoking rates. Advocates argue the policy hits low-income groups hardest and undermines Ireland’s public health goals.

As the WHO FCTC COP11 conference approaches, Joanna Junak speaks with tobacco policy expert Clive Bates on GFN News about the growing divide between science and ideology in global tobacco control. Bates warns that prohibitionist approaches risk fueling black markets and ignoring proven harm reduction strategies. Watch now to hear his call for a new evidence-based direction in nicotine and tobacco...

#GFN25 Science Discussion #4 | Introduction to Zanoprima's Synthetic Nicotine by GFN.TV

The World Health Organization is no longer just fighting smoking—it’s waging an ideological war against nicotine itself. In this blistering interview, former WHO official Professor Tikki Pang exposes how the global health establishment has become evidence-blind, influenced by Bloomberg funding, and driven by a moral crusade that erases the distinction between smoking and safer alternatives. From “...

Discover the real science behind effective vaping. In this episode, Joanna Junak talks with vaping science researcher Roberto Sussman about how power, airflow, and resistance shape vapor production, flavor, and efficiency. Learn why temperature control isn’t the key factor—and how adjusting wattage, coil resistance, and airflow settings can completely change your vaping experience. We explore: 🔥...

Watch this insightful Spanish-language session from the Global Forum on Nicotine 2025 #GFN25 featuring experts from across Latin America and beyond. The discussion explores tobacco harm reduction (THR), the fight against misinformation, and the role of communication, science, and consumer advocacy in shaping healthier public policies.

Social worker and health policy advocate Angelica Cabrera discusses the growing movement for tobacco harm reduction across Latin America. She shares regional experiences, challenges, and success stories that highlight how alternative nicotine products could transform public health outcomes — if supported by science-based policies.

“Challenging Perceptions” — hear voices from around the world on how to communicate tobacco harm reduction effectively. From researchers to advocates, GFN 2025 brought powerful insights on evidence, empathy, and engagement.